GY, et al. In vitro studies on cellular and mo-lecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelo-cytic leukemia: As2O3 induces NB4 cell ap-optosis with downregulation of Bcl-2 expres-sion and modulation of PML-RARa/PML proteins. Blood 1996;88:1052–61
Arsenic trioxide (As2O3) induces clinical remission in acute promyelocytic leukemia (APL) with minim...
Objective To investigate arsenic trioxide (As2O3)-induced apoptosis and the effects on cell nuclear ...
Background Arsenic trioxide (As2O3) has been identified as a very potent anti-acute leukemic agent. ...
Arsenic trioxide (As2O3) has recently been identified as an effective drug in the treatment of newly...
Introduction: Arsenic Trioxide (As2O3) causes antitumor effects by various mechanisms, including deg...
Arsenic trioxide (As2O3) is an effective drug for the treatment of acute promyelocytic leukemia (AP...
BACKGROUND: Retinoids, which are derivatives of vitamin A, induce differentiation of acute promyeloc...
BACKGROUND: Retinoids, which are derivatives of vitamin A, induce differentiation of acute promyel...
WOS: 000174932800010PubMed ID: 11839383Certain cell lines like HL 60 and K 562 are utilised as leuke...
Arsenic trioxide (As2O3) was recently identified as a very potent agent against acute promyelocytic ...
To investigate the mechanism of arsenic trioxide (As(2)O(3)) induced apoptosis in hepatic blastoma c...
Arsenic trioxide has recently been shown to inhibit growth and induce apoptosis in a variety of hema...
Arsenic trioxide (As2O3) was recently demonstrated to be an effective inducer of apoptosis in patien...
[[abstract]]Arsenic trioxide (As2O3) is used clinically to treat acute promyelocytic leukemia (APL) ...
Recent clinical studies have shown that inorganic arsenic trioxide (As(2)O(3)) at low concentrations...
Arsenic trioxide (As2O3) induces clinical remission in acute promyelocytic leukemia (APL) with minim...
Objective To investigate arsenic trioxide (As2O3)-induced apoptosis and the effects on cell nuclear ...
Background Arsenic trioxide (As2O3) has been identified as a very potent anti-acute leukemic agent. ...
Arsenic trioxide (As2O3) has recently been identified as an effective drug in the treatment of newly...
Introduction: Arsenic Trioxide (As2O3) causes antitumor effects by various mechanisms, including deg...
Arsenic trioxide (As2O3) is an effective drug for the treatment of acute promyelocytic leukemia (AP...
BACKGROUND: Retinoids, which are derivatives of vitamin A, induce differentiation of acute promyeloc...
BACKGROUND: Retinoids, which are derivatives of vitamin A, induce differentiation of acute promyel...
WOS: 000174932800010PubMed ID: 11839383Certain cell lines like HL 60 and K 562 are utilised as leuke...
Arsenic trioxide (As2O3) was recently identified as a very potent agent against acute promyelocytic ...
To investigate the mechanism of arsenic trioxide (As(2)O(3)) induced apoptosis in hepatic blastoma c...
Arsenic trioxide has recently been shown to inhibit growth and induce apoptosis in a variety of hema...
Arsenic trioxide (As2O3) was recently demonstrated to be an effective inducer of apoptosis in patien...
[[abstract]]Arsenic trioxide (As2O3) is used clinically to treat acute promyelocytic leukemia (APL) ...
Recent clinical studies have shown that inorganic arsenic trioxide (As(2)O(3)) at low concentrations...
Arsenic trioxide (As2O3) induces clinical remission in acute promyelocytic leukemia (APL) with minim...
Objective To investigate arsenic trioxide (As2O3)-induced apoptosis and the effects on cell nuclear ...
Background Arsenic trioxide (As2O3) has been identified as a very potent anti-acute leukemic agent. ...
Add to ORKG